| News: |
|
Quantilabs - a Contract Research Division of Visiopharm Under the scientific supervision and direction of Dr. Rogely Waite Boyce DVM,PhD,DACVP as Director of Histopathology and Professor Hans Jørgen Gundersen, serving as Chief Scientific Advisor, Quantilabs is offering a flexible range of services including all the essential elements to execute a valid stereological analysis. Histological capabilities include expertise in preparation of cryo-, paraffin, vibratome and plastic-embedded sections in combination with immunohistochemistry and non-isotopic in situ hybridization customized to meet specific client needs for either 2-dimensional or 3-dimensional applications. » Read more Updated: 2008.08.27
Olympus Stereology WorkshopNovember 11-14, 2008 Alexandria, VA » Flyer » Brochure Updated: 2008.08.19
Press Release:Visiopharm announces exclusive license agreement with the Stereology and Electron Microscopy Research Laboratory at Aarhus University. Visiopharm today announced the closing of an exclusive license agreement with the Stereology and Electron Microscopy Research Laboratory at Aarhus University, Denmark. Under the terms of the agreement, Visiopharm will proceed the further development for automated quantitative microscopy of the "Proportionator", a novel stereological sampling strategy developed and patent protected by Dr. Jonathan Gardi, PhD together with Professors Hans Jørgen Gundersen and Jens Nyengaard. » Read more Updated: 2007.11.15
Press Release:The Danish National Advanced Technology Foundation has donated DKK 10 Million to a project coordinated by Visiopharm for early diagnosis of testicular cancer based on automated image analysis. By combining advanced molecular technologies for detection of early tumor biomarkers in semen samples with computer-controlled image acquisition and automated quantitative microscopy, a group of Danish scientists is developing a method for pre-symptomatic diagnosis of testicular cancer. » Read more Updated: 2007.10.15
Press Release:NorthCap Partners Invests in Danish Software Company Visiopharm Copenhagen, Denmark. NorthCap Partners invests in quantitative microscopy company, Visiopharm. Visiopharm is a leading developer and vendor of advanced quantitative microscopy software for the pharmaceutical industry and life-science research. » Read more Updated: 2007.10.05
Introducing RespiratopixThe Visiopharm Respiratopix© workstation is designed for Quantitative Microscopy in respiratory research. The technology is facilitating every step in the work-flow from tissue sections to scientifically valid quantitative end-points reflecting important tissue properties. » Download brochure For more information, email: » respiratopix @visiopharm.com Updated: 2007.09.17
|